The different behaviors of reparixin or danirixin depend on the specific target, such as targeting CXCL8, CXCR1/CXCR2 or CXCR2, or depend on the specific target cells, such as tumor cells or different immune cell subpopulations. Here, CXCL8 is linked to neoplasm.